Medtech company backs down from Pfizer TM oppositions
14-08-2018
mediaphotos / iStockphoto.com
Two trademark oppositions against Pfizer have been suspended as the parties are engaged in negotiations to settle the disputes.
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Trademark Trial and Appeal Board, TTAB, trademark opposition, Pfizer, medical technology,
